Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors
Annalisa Lonetti, Alessandra Cappellini, Antonino Spartà, et al.
Oncotarget (2015) Vol. 6, Iss. 12, pp. 10399-10414
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti‐Mays, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies
Valentina Cordoʹ, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, et al.
Blood Cancer Discovery (2020) Vol. 2, Iss. 1, pp. 19-31
Open Access | Times Cited: 102
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Targeting PI3K Signaling in Acute Lymphoblastic Leukemia
Vanessa Edna Sanchez, Cydney Nichols, Hye Na Kim, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 412-412
Open Access | Times Cited: 71
Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
Deborah Bongiovanni, Valentina Saccomani, Erich Piovan
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 9, pp. 1904-1904
Open Access | Times Cited: 63
Targeting the MAPK/ERK and PI3K/AKT Signaling Pathways Affects NRF2, Trx and GSH Antioxidant Systems in Leukemia Cells
Ewa Jasek-Gajda, Halina Jurkowska, Małgorzata Jasińska, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 633-633
Open Access | Times Cited: 56
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001
Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Blood Advances (2021) Vol. 6, Iss. 4, pp. 1329-1341
Open Access | Times Cited: 54
The PTEN tumor suppressor gene and its role in lymphoma pathogenesis
Xiaoxiao Wang, Huiqiang Huang, Ken H. Young
Aging (2015) Vol. 7, Iss. 12, pp. 1032-1049
Open Access | Times Cited: 64
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway
Annalisa Lonetti, Alessandra Cappellini, Alice Bertaina, et al.
Journal of Hematology & Oncology (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 59
Targeting Wnt/β‐catenin and PI3K/Akt/mTOR pathways in T‐cell acute lymphoblastic leukemia
Cecilia Evangelisti, Francesca Chiarini, Alessandra Cappellini, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 6, pp. 5413-5428
Closed Access | Times Cited: 49
The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response
Alberto M. Martelli, Francesca Paganelli, Antonietta Fazio, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 629-629
Open Access | Times Cited: 41
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB
Francesca Buontempo, Ester Orsini, Annalisa Lonetti, et al.
Oncotarget (2015) Vol. 7, Iss. 2, pp. 1323-1340
Open Access | Times Cited: 39
Phosphatidylinositol 3‐kinase inhibition potentiates glucocorticoid response in B‐cell acute lymphoblastic leukemia
Cecilia Evangelisti, Alessandra Cappellini, Mariana L. Oliveira, et al.
Journal of Cellular Physiology (2017) Vol. 233, Iss. 3, pp. 1796-1811
Open Access | Times Cited: 38
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL
Valentina Serafin, Valentina Lissandron, Barbara Buldini, et al.
Leukemia (2017) Vol. 31, Iss. 4, pp. 1007-1011
Open Access | Times Cited: 30
Marine bisindole alkaloid: A potential apoptotic inducer in human cancer cells
Sara Salucci, Sabrina Burattini, Francesca Buontempo, et al.
European Journal of Histochemistry (2018)
Open Access | Times Cited: 28
Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells
Elahe Naderali, Behnaz Valipour, Amir Afshin Khaki, et al.
Advanced Pharmaceutical Bulletin (2019) Vol. 9, Iss. 3, pp. 470-480
Open Access | Times Cited: 27
Marsdenia tenacissimaeextraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement
Ying Wang, Bingyu Chen, Zhen Wang, et al.
Oncotarget (2016) Vol. 7, Iss. 50, pp. 82851-82863
Open Access | Times Cited: 26
From the outside, from within: Biological and therapeutic relevance of signal transduction in T-cell acute lymphoblastic leukemia
Mariana L. Oliveira, Padma Akkapeddi, Isabel Alcobia, et al.
Cellular Signalling (2017) Vol. 38, pp. 10-25
Open Access | Times Cited: 25
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells
Stephen L. Abrams, Peter P. Ruvolo, Vivian Ruvolo, et al.
Oncotarget (2017) Vol. 8, Iss. 44, pp. 76525-76557
Open Access | Times Cited: 17
Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
Olga Ksionda, Marsilius Mues, Anica M. Wandler, et al.
PLoS ONE (2018) Vol. 13, Iss. 5, pp. e0193849-e0193849
Open Access | Times Cited: 17
Therapeutic potential of nvp‐bkm120 in human osteosarcomas cells
Alberto Bavelloni, Enrico Focaccia, Manuela Piazzi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 7, pp. 10907-10917
Closed Access | Times Cited: 17
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia
Ayman Ali Mohammed Alameen, Carolina Simioni, Alberto M. Martelli, et al.
Oncotarget (2016) Vol. 7, Iss. 34, pp. 55690-55703
Open Access | Times Cited: 16
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device
Francesca Buontempo, Ester Orsini, Isabella Zironi, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0199312-e0199312
Open Access | Times Cited: 16
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines
Simona Ultimo, Carolina Simioni, Alberto M. Martelli, et al.
Oncotarget (2017) Vol. 8, Iss. 14, pp. 23213-23227
Open Access | Times Cited: 15
CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia
Yun-Jung Chiang, Wei‐Ting Liao, Kun-Chin Ho, et al.
Oncogene (2018) Vol. 38, Iss. 9, pp. 1432-1447
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top